EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Ideal outcomes in pancreatic neuroendocrine tumor vs. adenocarcinoma following resection: A nationwide study using ACS-NSQIP

Jiage Qian, Sebastiaan Ceuppens, Nikhil V Tirukkovalur, Kenneth K Lee, Amer H Zureikat, Alessandro Paniccia

European Journal of Surgical Oncology · 2025

DOI: 10.1016/j.ejso.2025.110438 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Jiage Qian und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neuroendocrine Tumors, Pancreaticoduodenectomy, Postoperative Complications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Prior evidence suggests higher postoperative complications in pancreatic neuroendocrine tumors (pNET) compared to ductal adenocarcinoma (PDAC). This study refines the comparison using the Ideal Outcome (IO) metric and identifies predictors of IO. METHODS: A retrospective cohort study was performed using the 2014-2023 standard and pancreas-targeted ACS-NSQIP database to identify patients with PDAC or pNET who underwent pancreatoduodenectomy (PD) or distal pancreatectomy (DP). IO was defined as absence of clinically relevant postoperative pancreatic fistula (CR-POPF), prolonged length of stay (LOS), severe complications, reoperation, readmission, and mortality. RESULTS: A total of 25,290 PDAC and 4914 pNET patients were included. In PD, IO was lower in pNET (44.2 %) compared to PDAC (56.9 %, p < 0.001), with pNET having higher rates of severe complications (31.2 % vs. 19.0 %, p < 0.001), prolonged LOS (28.9 % vs. 25.8 %; p = 0.004), CR-POPF (26.7 % vs. 10.9 %; p < 0.001), and readmission (23.6 % vs. 15.3 %; p < 0.001). In contrast, pNET had higher IO after DP (60.1 % vs. 57.1 %; p = 0.008), with higher CR-POPF (19.2 % vs. 13.4 %; p < 0.001) but lower prolonged LOS (18.5 % vs. 26.4 %; p < 0.001). In PD, predictors of lower IO for both histologies included male sex (PDAC aOR 0.83; pNET 0.60), obesity (0.77; 0.63), hypertension (0.89; 0.79), small duct (0.81; 0.75), and soft gland (0.62; 0.57). In DP, minimally invasive surgery was associated with higher IO in both cancer types (PDAC aOR 1.71; pNET 1.52; all p < 0.05). CONCLUSION: Compared to PDAC, IO rate for pNET was lower after PD but higher after DP. CR-POPF was consistently higher in pNET, while other components of IO varied by procedure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeuroendocrine TumorsPancreaticoduodenectomyPostoperative ComplicationsPancreatectomyCarcinoma, Pancreatic DuctalAdenocarcinomaHumansMaleFemaleRetrospective StudiesMiddle AgedAgedLength of StayPatient ReadmissionReoperationPancreatic Fistula

Stichwörter der Autor:innen

Distal pancreatectomyIdeal outcomePancreatic ductal adenocarcinomaPancreatic neuroendocrine tumorsPancreatoduodenectomyPostoperative complications

Autor:innen und Institutionen

  • University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Electronic address: panicciaa2@upmc.edu.

Zitieren

APA

Qian, J., Ceuppens, S., Tirukkovalur, N. V., Lee, K. K., Zureikat, A. H., & Paniccia, A. (2025). Ideal outcomes in pancreatic neuroendocrine tumor vs. adenocarcinoma following resection: A nationwide study using ACS-NSQIP. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110438

Vancouver

Qian J, Ceuppens S, Tirukkovalur NV, Lee KK, Zureikat AH, Paniccia A. Ideal outcomes in pancreatic neuroendocrine tumor vs. adenocarcinoma following resection: A nationwide study using ACS-NSQIP. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110438

BibTeX
@article{Qian2025,
  author = {Qian, Jiage and Ceuppens, Sebastiaan and Tirukkovalur, Nikhil V and Lee, Kenneth K and Zureikat, Amer H and Paniccia, Alessandro},
  title = {Ideal outcomes in pancreatic neuroendocrine tumor vs. adenocarcinoma following resection: A nationwide study using ACS-NSQIP},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1016/j.ejso.2025.110438}
}
Kostenlos starten →